|
注册号: Registration number: |
ChiCTR2400085385 |
|
最近更新日期: Date of Last Refreshed on: |
2024-06-06 10:43:16 |
|
注册时间: Date of Registration: |
2024-06-06 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
柔性神经记录电极在局麻开颅手术中实时记录脑电与解码研究 |
|
Public title: |
Hyperflexible neural recording electrodes for real-time neural recording and decoding studies in craniotomy under local anesthesia |
|
注册题目简写: |
颅内超柔性微电极在立体定向手术中安全性和有效性探索性研究 |
|
English Acronym: |
An exploratory study on the safety and effectiveness of intracranial hyperflexible neural electrode in stereotactic surgery |
|
研究课题的正式科学名称: |
柔性神经记录电极在局麻开颅手术中实时记录脑电与解码研究 |
|
Scientific title: |
Hyperflexible neural recording electrodes for real-time neural recording and decoding studies in craniotomy under local anesthesia |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
李大鹏 |
研究负责人: |
闫志强 |
|
Applicant: |
Dapeng Li |
Study leader: |
Zhiqiang Yan |
|
申请注册联系人电话: Applicant telephone: |
+86 186 0212 3320 |
研究负责人电话:
Study leader's |
+86 136 7925 2326 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
lidapeng@stairmed.com |
研究负责人电子邮件: Study leader's E-mail: |
zhiqiangyan-xj@outlook.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国(上海)自由贸易试验区巴圣路160号4幢1单元4层 |
研究负责人通讯地址: |
西安市新城区长乐西路127号 |
|
Applicant address: |
4th Floor, Unit 1, Building 4, No. 160, Basheng Road, China (Shanghai) Pilot Free Trade Zone |
Study leader's address: |
No. 127, Changle West Road, Xincheng District, Xi'an |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海阶梯医疗科技有限公司 |
||
|
Applicant's institution: |
Shanghai StairMed Technology Co., Ltd. |
||
|
研究负责人所在单位: |
西京医院 |
||
|
Affiliation of the Leader: |
Xijing Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KY20232366-F-1 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国人民解放军空军军医大学第一附属医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of the First Affiliated Hospital of Air Force Medical University of Chinese People's Liberation Army |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-12-28 00:00:00 | ||
|
伦理委员会联系人: |
贾艳艳 |
||
|
Contact Name of the ethic committee: |
Yanyan Jia |
||
|
伦理委员会联系地址: |
西安市新城区长乐西路127号 |
||
|
Contact Address of the ethic committee: |
No. 127, Changle West Road, Xincheng District, Xi'an |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 29 8477 1794 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
西京医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Xijing Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
西安市新城区长乐西路127号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 127, Changle West Road, Xincheng District, Xi'an |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
上海阶梯医疗科技有限公司 |
||||||||||||||||||||||
|
Source(s) of funding: |
Shanghai StairMed Technology Co., Ltd. |
||||||||||||||||||||||
|
研究疾病: |
立体定向手术相关疾病 |
||||||||||||||||||||||
|
Target disease: |
Stereotactic surgery related diseases |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||
|
研究目的: |
研发国产柔性电生理记录电极,用于脑深度电刺激术中电生理电位,替代进口产品,在此基础上,搭建清醒状态人颅内多通道单细胞记录研究平台,服务脑科学研究。 |
||||||||||||||||||||||
|
Objectives of Study: |
Develop domestically produced hyperflexible neural electrodes for electrophysiological potentials during deep brain stimulation, replacing imported products. On this basis, a multi-channel single-cell recording research platform in the awake human brain will be built to serve brain research. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
(1) 有明显的认知功能障碍; (2) 有严重(难治性)抑郁、焦虑、精神分裂症等精神类疾病; (3) 长期服用特殊药物者,如免疫抑制剂、激素、抗凝药等; (4) 过敏体质,有药物过敏史,对手术器械或者药物过敏者; (5) 存在全身麻醉、开颅或手术禁忌症; (6) 近 6 个月内诊断为急性心肌梗死或心脏骤停; (7) 研究者认为具有其他神经外科禁忌症的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) There is obvious cognitive dysfunction; (2) Have severe (refractory) depression, anxiety, schizophrenia and other mental illnesses; (3) Those who take special drugs for a long time, such as immunosuppressants, hormones, anticoagulants, etc.; (4) Those with allergies, history of drug allergy, or allergies to surgical instruments or drugs; (5) There are contraindications for general anesthesia, craniotomy or surgery; (6) Diagnosed with acute myocardial infarction or cardiac arrest within the past 6 months; (7) Patients who have other contraindications to neurosurgery in the opinion of the investigator. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-01-01 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-06-17 00:00:00 至 To 2025-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
计划在试验结束、文章发表后(预计在2025年12月31日前),进行原始数据共享。数据共享平台计划为GitHub,https://github.com/。具体的数据共享方式会在试验结束、文章发表后公布,将在“研究计划书或研究结果报告发表信息”部分进行说明。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
It is planned to share the original data after the trial is completed and the article is published (expected to be before December 31, 2025). The data sharing platform is planned to be GitHub, https://github.com/. The specific data sharing method will be announced after the trial is completed and the article is published, and will be explained in the "Research Proposal or Research Results Report Publication Information" section. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |